<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC11371520</article-id>
        <article-id pub-id-type="pmcid-ver">PMC11371520.1</article-id>
        <article-id pub-id-type="pmcaid">11371520</article-id>
        <article-id pub-id-type="pmcaiid">11371520</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS2007508</article-id>
        <article-id pub-id-type="pmid">38949888</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-23-3403</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS2007508</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA2007508</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Lenis</surname>
              <given-names initials="AT">Andrew T.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ravichandran</surname>
              <given-names initials="V">Vignesh</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Brown</surname>
              <given-names initials="S">Samantha</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Alam</surname>
              <given-names initials="SM">Syed M.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Katims</surname>
              <given-names initials="A">Andrew</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Truong</surname>
              <given-names initials="H">Hong</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Reisz</surname>
              <given-names initials="PA">Peter A.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Vasselman</surname>
              <given-names initials="S">Samantha</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Nweji</surname>
              <given-names initials="B">Barbara</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Autio</surname>
              <given-names initials="KA">Karen A.</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Morris</surname>
              <given-names initials="MJ">Michael J.</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Slovin</surname>
              <given-names initials="SF">Susan F.</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Rathkopf</surname>
              <given-names initials="D">Dana</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Danila</surname>
              <given-names initials="D">Daniel</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Scher</surname>
              <given-names initials="HI">Howard I.</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Woo</surname>
              <given-names initials="S">Sungmin</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Vargas</surname>
              <given-names initials="HA">Hebert Alberto</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Laudone</surname>
              <given-names initials="VP">Vincent P.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ehdaie</surname>
              <given-names initials="B">Behfar</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Reuter</surname>
              <given-names initials="V">Victor</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Arcila</surname>
              <given-names initials="M">Maria</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Berger</surname>
              <given-names initials="MF">Michael F.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Viale</surname>
              <given-names initials="A">Agnes</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Schultz</surname>
              <given-names initials="N">Nikolaus</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gopalan</surname>
              <given-names initials="A">Anuradha</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Donoghue</surname>
              <given-names initials="MTA">Mark T.A.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Ostrovnaya</surname>
              <given-names initials="I">Irina</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Stopsack</surname>
              <given-names initials="KH">Konrad H.</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Solit</surname>
              <given-names initials="DB">David B.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="A7" ref-type="aff">7</xref>
            <xref rid="FN1" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Abida</surname>
              <given-names initials="W">Wassim</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="CR1" ref-type="corresp">*</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Urology Section, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065</aff>
        <aff id="A2"><label>2</label>Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065</aff>
        <aff id="A3"><label>3</label>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065</aff>
        <aff id="A4"><label>4</label>Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065</aff>
        <aff id="A5"><label>5</label>Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065</aff>
        <aff id="A6"><label>6</label>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065</aff>
        <aff id="A7"><label>7</label>Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065</aff>
        <author-notes>
          <fn id="FN1">
            <label>*</label>
            <p id="P1">co-senior/corresponding authors</p>
          </fn>
          <corresp id="CR1"><bold>Corresponding authors:</bold> Wassim Abida, 353 East 68<sup>th</sup> Street, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY 10065, <email>abidam@mskcc.org</email>, Fax: 646-227-2417, David B. Solit, 353 East 68<sup>th</sup> Street, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY 10065, <email>solitd@mskcc.org</email></corresp>
          <fn fn-type="COI-statement" id="FN2">
            <p id="P34">Declaration of Interests:</p>
            <p id="P35">WA received speaking honoraria from Roche, Pfizer, Medscape, Aptitude Health, Clinical Education Alliance, touchIME and Onclive/MJH Life Sciences, consulting fees from Clovis Oncology, Janssen, ORIC Pharmaceuticals, Daiichi Sankyo and AstraZeneca, and Research Funding (to his institution) from AstraZeneca, Zenith Epigenetics, Clovis Oncology, ORIC Pharmaceuticals, Epizyme, and Nuvation Bio.</p>
            <p id="P36">D.R. is an uncompensated Advisor and/or Steering Committee member and has received Research Support (PI): Janssen, Astra Zeneca, Bayer, Myovant, Genentech, Promontory, BMS/Celgene</p>
            <p id="P37">M.F.B. has received consulting fees from Eli Lilly, AstraZeneca, and Paige.AI.</p>
            <p id="P38">D.B.S. has served as a consultant for/received honorarium from Pfizer, Loxo/Lilly Oncology, Vividion Therapeutics, Scorpion Therapeutics, Fore Therapeutics, FOG Pharma, Rain Therapeutics, Function Oncology, Elsie Biotherapeutics, and BridgeBio.</p>
            <p id="P39">All other authors have no relevant declarations of interest.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>03</day>
          <month>9</month>
          <year>2024</year>
        </pub-date>
        <volume>30</volume>
        <issue>17</issue>
        <issue-id pub-id-type="pmc-issue-id">469988</issue-id>
        <fpage>3894</fpage>
        <lpage>3903</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>18</day>
              <month>07</month>
              <year>2024</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>03</day>
              <month>03</month>
              <year>2025</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>03</day>
              <month>03</month>
              <year>2025</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2025-03-03 00:25:38.517">
              <day>03</day>
              <month>03</month>
              <year>2025</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2007508.pdf"/>
        <abstract id="ABS1">
          <sec id="S1">
            <title>Purpose:</title>
            <p id="P2">Patients with microsatellite instability high/mismatch repair deficient (MSI-H/dMMR) and high tumor mutational burden (TMB-H) prostate cancers are candidates for pembrolizumab. We define the genomic features, clinical course, and response to immune checkpoint blockade (ICB) in patients with MSI-H/dMMR and TMB-H prostate cancers without MSI (TMB-H/MSS).</p>
          </sec>
          <sec id="S2">
            <title>Methods:</title>
            <p id="P3">We sequenced 3,244 tumors from 2,257 prostate cancer patients. MSI-H/dMMR prostate cancer was defined as MSIsensor score ≥10 or MSIsensor score ≥3 and &lt;10 with a deleterious MMR alteration. TMB-H was defined as ≥10 mutations/megabase. PSA<sub>50</sub> and RECIST responses were assigned. Overall survival (OS) and radiographic progression-free survival (rPFS) were compared using log rank test.</p>
          </sec>
          <sec id="S3">
            <title>Results:</title>
            <p id="P4">63 (2.8%) men had MSI-H/dMMR and 33 (1.5%) had TMB-H/MSS prostate cancers. Patients with MSI-H/dMMR and TMB-H/MSS tumors more commonly presented with grade group 5 and metastatic disease at diagnosis. MSI-H/dMMR tumors had higher TMB, indel and neoantigen burden compared with TMB-H/MSS. 27 patients with MSI-H/dMMR and 8 patients with TMB-H/MSS tumors received ICB, none of whom harbored <italic toggle="yes">POLE</italic> mutations. 45% of MSI-H/dMMR patients had a RECIST response and 65% had a PSA<sub>50</sub> response. No TMB-H/MSS patient had a RECIST response and 50% had a PSA<sub>50</sub> response. rPFS tended to be longer in MSI-H/dMMR patients than in TMB-H/MSS patients who received immunotherapy. Pronounced differences in genomics, TMB or MSIsensor score were not detected between MSI-H/dMMR responders and non-responders.</p>
          </sec>
          <sec id="S4">
            <title>Conclusions:</title>
            <p id="P5">MSI-H/dMMR prostate cancers have greater TMB, indel and neoantigen burden compared with TMB-H/MSS prostate cancers, and these differences may contribute to more profound and durable responses to ICB.</p>
          </sec>
        </abstract>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
